Guillaume Pfefer, CEO of Senda Biosciences & Flagship Pioneering CEO-Partner, describes Senda’s work to unlock comprehensive programming of medicine and what is in store for the company in the year ahead. More from Flagship @ JPM2023 here.
More from:
Human Health
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
Halting the Trajectory of Disease with Preemptive Health
AI in Action
2025 CEO Chat: Torben Straight Nissen, CEO of Repertoire Immune Medicines
